Drugs That May Affect Radiopharmaceutical Distribution/Labeling in Cardiac Ejection Fraction Imaging Studies Using 99mTc RBC |
|
Causative Drug |
Appearance on Scintiphotos or Effect on Labeling |
Adriamycin |
Decreased RBC labeling efficiency; abnormal response to exercise by left ventricle |
Calcium channel blockers |
Appearance of normal exercise test in presence of CAD |
β- Blockers |
Decreased wall motion with exercise |
Cessation of thyroxine |
Increased thyroid uptake |
Digoxin |
Decreased RBC labeling efficiency |
Doxorubicin |
Decreased RBC labeling efficiency |
Heparin |
Decreased RBC labeling efficiency |
Hydralazine |
Decreased RBC labeling efficiency; poor cardiac border definition |
Iodinated radiopaque contrast media |
Decreased ABC labeling efficiency contrast media |
Methyldopa |
Decreased RBC labeling efficiency due |
Prazocin |
Decreased RBC labeling efficiency |
Propranolol |
Decreased ABC labeling efficiency; false negative response to exercise; masks CAD |
Quinidine |
Decreased ABC labeling efficiency due to induced ABC antibody formation |